Transplantation of Human Embryonic Stem Cells in Patients with Multiple Sclerosis and Lyme Disease
Multiple sclerosis (MS) is an inflammatory and neurodegenerative disease in which the myelin sheath of nerve cells is damaged.
Multiple sclerosis (MS) is an inflammatory and neurodegenerative disease in which the myelin sheath of nerve cells is damaged.
Human embryonic stem cells are pluripotent cell lines usually derived from human blastocysts.
To describe the morphogenesis of different neuronal cells from the human embryonic stem cell (hESC) line, SCT-N, under in vitro culture conditions.
The expanded disability status scale (EDSS) is a validated and reliable tool to assess the extent of disabilities in patients with multiple sclerosis (MS)
The major complication faced by patients with chronic static spinal cord injury (SCI) is the loss of mobilization.
Multiple sclerosis (MS) is a common neurological disease characterized by recurrent relapses within the central nervous system (CNS)
To evaluate the safety and efficacy of human embryonic stem cells (hESCs) for the management of type 2 diabetes mellitus (T2DM)
Human embryonic stem cells (hESCs) have a role in treating neurological disorders. The efficacy and safety of hESC in treating spinal cord injury (SCI) was reported in our previous study.
Down syndrome (DS) is a common chromosomal disorder caused by trisomy of chromosome 21 (HSA21q). Individuals with DS suffer from various congenital and progressive diseases
Crohn’s disease is a chronic inflammatory disease of the intestines, mainly the colon and ileum, related with ulcers and fistulae.
Thanks for contacting ReoStem! We have received your response and we will get back to you shortly.